The Effect of Switching Patients With Symptomatic Benign Prostatic Hyperplasia From Tamsulosin 0.2 Mg to 0.4 Mg

Open Journal of Urology
doi 10.4236/oju.2013.32021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

Clinical Significance of Prostatic-Urethral Angulation on the Treatment Outcome of Patients With Symptomatic Benign Prostatic Hyperplasia Treated With Tamsulosin Hydrochloride

Archivio Italiano di Urologia Andrologia
Urology
2015English

Combined Analysis of Two Multicenter Studies of Finasteride 5 Mg in the Treatment of Symptomatic Benign Prostatic Hyperplasia

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
1997English

Tamsulosin Versus Terazosin for Benign Prostatic Hyperplasia: A Systematic Review

Systems Biology in Reproductive Medicine
Reproductive MedicineUrology
2009English

The Predictive Ability of Response to First Dose of Tamsulosin in Symptomatic Patient With Benign Prostatic Obstruction

Al-Azhar International Medical Journal
2020English

The Efficacy & Safety of Trospium Chloride in Combination With Tamsulosin for Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

Urology & Nephrology Open Access Journal
2018English

Benign Prostatic Hyperplasia

Journal of Urology
Urology
2010English

Benign Prostatic Hyperplasia

Journal of Urology
Urology
2011English

Benign Prostatic Hyperplasia

Journal of Urology
Urology
2010English

Figure 5: Six Samples Through Freeze Drying to Compound With Five Gradient Concentrations (0.0 Mg/mL, 0.2 Mg/mL, 0.4 Mg/mL, 0.6 Mg/mL, 0.8 Mg/mL, 1.0 Mg/mL) , Use the Ascorbic Acid (Vc) as the Control.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy